Bladder Tumors Invading the Lamina propria (Stage A/Tl): Influence of Endovesical Bacillus Calmette-Guérin Therapy on Recurrence and Progression
- 1 January 1989
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 16 (6) , 401-404
- https://doi.org/10.1159/000471630
Abstract
47 patients with transitional cell bladder carcinoma invading the lamina propria (stage A/Ti) were treated from 1984 to 1986 by complete transurethral resection followed by 1-3 cycles of endovesical bacillus Calmette- Guérin instillations, and followed 14-64 months by cytology, endoscopy and bladder biopsies. 64% achieved a complete response. 36% recurred (recurrence rate/100 months/patient 2.2), 21% progressed to muscle invasion. Duration of treatment, tumor size or type (solid vs. papillary), presence of carcinoma in situ bore no relation to the final result. The preceding history of T[ bladder tumor appeared associated with a higher risk of progression although not reaching statistical significance. The results were compared to those obtained by transurethral resection in a similar group of 50 patients treated from 1982 to 1984 and followed up 12-100 months. 90% recurred and 34% progressed to muscle invasion with a recurrence rate/100 months/patient of 9.22. Keeping in mind the limits of a nonrandomized historical comparison, it appears that endovesical bacillus Calmette-Guérin therapy alters favorably the recurrence pattern of T i bladder cancer.Keywords
This publication has 14 references indexed in Scilit:
- Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in SituJournal of Urology, 1985
- The Management of Superficial Bladder Tumors and Carcinoma in situ with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1985
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative GroupJournal of Urology, 1983
- Ta and T1 Bladder Cancer: Location, Recurrence and Progression†British Journal of Urology, 1982
- Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 CasesJournal of Urology, 1982